Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

13,800

Employees13,800

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

13,800

Employees13,800

ZTS Key Statistics

Market cap

68.99B

Market cap68.99B

Price-Earnings ratio

28.52

Price-Earnings ratio28.52

Dividend yield

1.17%

Dividend yield1.17%

Average volume

2.79M

Average volume2.79M

High today

$157.63

High today$157.63

Low today

$154.71

Low today$154.71

Open price

$157.35

Open price$157.35

Volume

2.27M

Volume2.27M

52 Week high

$200.33

52 Week high$200.33

52 Week low

$139.70

52 Week low$139.70

ZTS News

TipRanks 21h

Zoetis Maintains Strong Market Position Despite New Competition, Analyst Recommends Buy

Analyst Michael Ryskin of Bank of America Securities maintained a Buy rating on Zoetis, retaining the price target of $200.00. Don’t Miss TipRanks’ Half-Year S...

Benzinga 4d

Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost

JPMorgan upgraded Phibro Animal Health Corporation PAHC, citing strong execution following its $350 million acquisition of Zoetis' medicated feed additive and w...

Analyst ratings

85%

of 20 ratings

Buy

85%

Hold

15%

Sell

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.